- Home
- MG vs VNDA Comparison
MG vs VNDA Comparison
Compare MG & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MG
- VNDA
- Stock Information
- Founded
- MG 1978
- VNDA 2002
- Country
- MG United States
- VNDA United States
- Employees
- MG N/A
- VNDA N/A
- Industry
- MG Military/Government/Technical
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- MG Consumer Discretionary
- VNDA Health Care
- Exchange
- MG Nasdaq
- VNDA Nasdaq
- Market Cap
- MG 278.5M
- VNDA 270.0M
- IPO Year
- MG 2009
- VNDA 2006
- Fundamental
- Price
- MG $9.84
- VNDA $4.51
- Analyst Decision
- MG Hold
- VNDA Strong Buy
- Analyst Count
- MG 1
- VNDA 2
- Target Price
- MG $11.00
- VNDA $15.50
- AVG Volume (30 Days)
- MG 149.4K
- VNDA 499.8K
- Earning Date
- MG 03-05-2025
- VNDA 02-05-2025
- Dividend Yield
- MG N/A
- VNDA N/A
- EPS Growth
- MG N/A
- VNDA N/A
- EPS
- MG 0.36
- VNDA N/A
- Revenue
- MG $738,983,000.00
- VNDA $190,858,000.00
- Revenue This Year
- MG $6.49
- VNDA $5.60
- Revenue Next Year
- MG $2.75
- VNDA $42.85
- P/E Ratio
- MG $27.94
- VNDA N/A
- Revenue Growth
- MG 6.85
- VNDA N/A
- 52 Week Low
- MG $7.45
- VNDA $3.46
- 52 Week High
- MG $12.44
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- MG 67.43
- VNDA 42.95
- Support Level
- MG $8.78
- VNDA $4.77
- Resistance Level
- MG $9.67
- VNDA $4.95
- Average True Range (ATR)
- MG 0.25
- VNDA 0.15
- MACD
- MG 0.11
- VNDA -0.03
- Stochastic Oscillator
- MG 86.89
- VNDA 31.82
About MG Mistras Group Inc
MISTRAS Group Inc provides asset protection solutions and systems. The company evaluates the structural integrity and reliability of critical energy, industrial, and public infrastructure. The company's three operating segments are North America, International and Products and Systems, of which key revenue is derived from the North America segment. Services segment provides asset protection solutions predominantly in North America, with the large amount of concentration in the United States, followed by Canada, consisting of non-destructive testing, and inspection. The asset protection solutions include field inspections, consulting, maintenance, data management, access, monitoring and laboratory quality assurance.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.